Impact of time of day on outcomes after stereotactic radiosurgery for non-small cell lung cancer brain metastases

Cancer

Volumn 119, Issue 19, 2013, Pages 3563-3569

  Badiyan, Shahed N ^a   Ferraro, Daniel J ^a   Yaddanapudi, Sridhar ^a   Drzymala, Robert E ^a   Lee, Andrew Y ^a   Silver, Shawgi A ^a   Dyk, Pawel ^a   Dewees, Todd ^a   Simpson, Joseph R ^a   Rich, Keith M ^b   Robinson, Clifford G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

brain metastases; chronobiology; circadian rhythm; Gamma Knife; local control; non small cell lung cancer; radiosurgery; survival; time of day

Indexed keywords

ADULT; ARTICLE; BRAIN METASTASIS; CANCER RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRADED PROGNOSTIC ASSESSMENT SCORE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STEREOTACTIC RADIOSURGERY; TIME TO TREATMENT; TUMOR VOLUME;

BRAIN METASTASES; CHRONOBIOLOGY; CIRCADIAN RHYTHM; GAMMA KNIFE; LOCAL CONTROL; NON-SMALL CELL LUNG CANCER; RADIOSURGERY; SURVIVAL; TIME OF DAY;

BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CHRONOBIOLOGY PHENOMENA; CIRCADIAN RHYTHM; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RADIOSURGERY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84884906784     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28237     Document Type: Article

References (24)

1. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004; 363: 1665-1672.
2. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009; 10: 1037-1044.
3. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006; 295: 2483-2491.
4. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD,. Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys. 2006; 64: 898-903.
5. Alexander E 3rd, Moriarty TM, Davis RB, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst. 1995; 87: 34-40.
6. Mehta MP, Rozental JM, Levin AB, et al. Defining the role of radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys. 1992; 24: 619-625.
7. Kim DG, Chung HT, Gwak HS, Paek SH, Jung HW, Han DH,. Gamma knife radiosurgery for brain metastases: prognostic factors for survival and local control. J Neurosurg. 2000; 93 (suppl 3): 23-29.
8. Sperduto PW, Kased N, Roberge D, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol. 2012; 30: 419-425.
9. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997; 37: 745-751.
10. Weltman E, Salvajoli JV, Brandt RA, et al. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys. 2000; 46: 1155-1161.
11. Li J, Bentzen SM, Renschler M, Mehta MP,. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol. 2007; 25: 1260-1266.
12. Suh JH, Stea B, Nabid A, et al. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. J Clin Oncol. 2006; 24: 106-114.
13. Sperduto PW, Wang M, Robins HI, et al. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320. Int J Radiat Oncol Biol Phys. 2013; 85: 1312-1318.
14. Cotta-Ramusino C, McDonald ER 3rd, Hurov K, Sowa ME, Harper JW, Elledge SJ,. A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling. Science. 2011; 332: 1313-1317.
15. Pawlik TM, Keyomarsi K,. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 2004; 59: 928-942.
16. Sinclair WK,. Cyclic x-ray responses in mammalian cells in vitro. Radiat Res. 1968; 33: 620-643.
17. Ijiri K, Potten CS,. Circadian rhythms in the incidence of apoptotic cells and number of clonogenic cells in intestinal crypts after radiation using normal and reversed light conditions. Int J Radiat Biol Relat Stud Phys Chem Med. 1988; 53: 717-727.
18. Newsome-Tabatabai R, Rushton PS,. Daily variation in radiosensitivity of circulating blood cells and bone marrow cellularity of mice. Comp Biochem Physiol A Comp Physiol. 1984; 78: 779-783.
19. Ijiri K, Potten CS,. The circadian rhythm for the number and sensitivity of radiation-induced apoptosis in the crypts of mouse small intestine. Int J Radiat Biol. 1990; 58: 165-175.
20. El-Mofty SK, Hovenga TL, Russell JE, Simmons DJ,. Parotid radiosensitivity changes: a temporal relation to glandular circadian rhythms. Int J Radiat Biol Relat Stud Phys Chem Med. 1982; 41: 335-342.
21. Rahn DA 3rd, Ray DK, Schlesinger DJ, et al. Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment? Cancer. 2011; 117: 414-420.
22. Williams BA, Mandrekar MJ, Mandrekar SJ, Cha SS, Furth AF,. Finding optimal cutpoints for continuous covariates with binary and time-to-event outcomes. Mayo Foundation Technical Report Series, no. 79. Rochester, MN: Department of Health Sciences Research, Mayo Clinic; 2006.
23. Bjarnason GA, Mackenzie RG, Nabid A, et al. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3). Int J Radiat Oncol Biol Phys. 2009; 73: 166-172.
24. Shukla P, Gupta D, Bisht SS, et al. Circadian variation in radiation-induced intestinal mucositis in patients with cervical carcinoma. Cancer. 2010; 116: 2031-2035.